UNSPSC 85515342: Supplement right posterior tibial artery with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right posterior tibial artery with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UR07Z

UNSPSC 85515342, Supplement right posterior tibial artery with autologous tissue substitute, open approach (Commodity), does not align with the state and local procurement activity currently tagged to this code. The recent opportunities show no surgical vascular procedures; instead, they reflect medical evaluation services, pharmacy benefit management, occupational health surveillance, and temporary clinical staffing — none of which involve arterial surgery or tissue grafting. The code appears misapplied to these opportunities, and the source provides no solicitations actually procuring the vascular surgical service the code nominally describes.

State and local issuing bodies posting under this code include county health systems, county commissioners' offices, state transportation departments, county juvenile probation departments, municipal pension boards, and cities with public employee health plans. The geographic spread spans Arizona (City of Phoenix Retirement Office), California (City of Long Beach, County of Santa Clara), Florida (Collier County), Texas (Harris County), and Washington (Washington State Department of Transportation). The recent opportunities reflect a fragmented mix of administrative, occupational health, and clinical staffing needs across different government service lines, with no concentration in any particular jurisdiction or service category. The mismatch between the code's surgical scope and the actual opportunities posted suggests either a systematic tagging error in the procurement database or that this code should not be a focus area for vendors in surgical vascular services or tissue substitute procurement.